Neuraptive Therapeutics

About:

Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries.

Website: http://www.neuraptive.com

Twitter/X: Neuraptive

Top Investors: Ben Franklin Technology Partners, New Rhein, Central Texas Angel Network

Description:

Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries. Neuraptive was founded to commercialize innovative technology from the University of Texas. Its franchise therapeutics product is designed for administration during surgery to improve outcomes for patients impacted by acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves. Founded in 2016, Neuraptive Therapeutics is headquartered in Lafayette, Colorado.

Total Funding Amount:

$20M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Lafayette, Colorado, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)neuraptive.com

Founders:

David Jackson

Number of Employees:

1-10

Last Funding Date:

2022-10-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai